The Trump administration’s revived rule to end rebates that drugmakers give to middlemen in Medicare is awaiting approval from the Office of Management and Budget and a final rule could be imminent, according to a person familiar with the matter.

The administration has said the rule would drive down the prices consumers pay for prescription drugs. An earlier version of the rule, a signature part of President Trump’s plan to lower drug prices, was withdrawn in 2019 because some White House advisers raised concerns that it could…

This post first appeared on wsj.com

You May Also Like

McConnell rejects Senate GOP election head Rick Scott’s 2022 agenda

WASHINGTON — Senate Minority Leader Mitch McConnell, R-Ky., rejected the proposed agenda…

Venezuela will hold military exercises off its shores as a British warship heads to Guyana

BOGOTA, Colombia — President Nicolás Maduro ordered Venezuela’s armed forces to conduct…

Little League Baseball, a coach and his wife sued for alleged sexual assault of 8 boys in Texas

The families of eight boys in Texas sued Little League Baseball Inc.…

Texas woman dead after teens allegedly fired 100 rounds and ‘hit the wrong house’ in drive-by shooting, sheriff says

Two teenagers were arrested after Texas deputies said they allegedly fired 100…